The present invention relates to compounds according to the general formula (I)
which bind to the nuclear receptor, NR1H4, and act as agonists and antagonists
of the NR1H4 receptor. The invention further relates to the treatment of diseases
and/or conditions through binding of the nuclear receptor by the compounds.